Local and systemic delivery of low molecular weight heparin stimulates the reendothelialization after balloon angioplasty

Cardiovascular Research

Volumn 38, Issue 3, 1998, Pages 751-762

  Oberhoff, Martin ^a   Novak, Simon ^a   Herdeg, Christian ^a   Baumbach, Andreas ^a   Kranzhöfer, Alexander ^a   Bohnet, Armin ^a   Horch, Barbara ^a   Hanke, Hartmut ^b   Haase, Karl K ^a   Karsch, Karl R ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Endothelium; Local drug delivery; Low molecular weight heparin; PECAM1; Rabbits; Von Willebrand factor

Indexed keywords

BROXURIDINE; CD31 ANTIGEN; LOW MOLECULAR WEIGHT HEPARIN; MONOCLONAL ANTIBODY; REVIPARIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; MORPHOMETRICS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; RESTENOSIS; SCANNING ELECTRON MICROSCOPY; SUBCUTANEOUS DRUG ADMINISTRATION; TISSUE REGENERATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; ANGIOPLASTY, BALLOON; ANIMALS; ARTERIOSCLEROSIS; CAROTID ARTERIES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HISTOLOGICAL TECHNIQUES; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICROSCOPY, ELECTRON, SCANNING; MUSCLE, SMOOTH, VASCULAR; RABBITS; REGENERATION; STIMULATION, CHEMICAL;

EID: 0032104422     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00049-2     Document Type: Article

References (45)

1. [1] Vane JR, Änggard EE, Bolting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
2. [2] Becker RC. Seminars in thrombosis, thrombolysis and vascular biology: I. The vascular endothelium. Cardiology 1991;78:13-22.
3. [3] Furchgott RF. Role of endothelium in responses of smooth muscle. Circ Res 1983;53:557-573.
4. [4] Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
5. [5] Castellot JJ, Addonzio ML, Rosenberg M, Karnovsky MJ. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J Cell Biol 1981;90:372-379.
6. [6] Castellot JJ, Wright TC, Karnovsky MJ. Regulation of smooth muscle cell growth by heparin and heparan sulfates. Semin Thromb Hemost 1987;13:487-503.
7. [7] Scott-Burden T, Vanhoutte PM. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation 1993;87(V):51-55. Suppl. V.
8. [8] Nabel EG. Biology of the impaired endothelium. Am J Cardiol 1991;68:6C-8C.
9. [9] Ross R, Faggiotto A, Bowen-Pope D, Raines E. The role of endothelial injury and platelet and macrophage interactions in atherosclerosis. Circulation 1984;70(III):77-82. Suppl III.
10. [10] Fischell TA, Nellesen U, Johnson DE, Ginsburg R. Endothelium-dependent arterial vasoconstriction after balloon angioplasty. Circulation 1989;79:899-910.
11. [11] Harrison DG. Endothelial modulation of vascular tone: Relevance to coronary angioplasty and restenosis. J Am Coll Cardiol 1991;17:71B-76B.
12. [12] Guyton J, Rosenberg R, Clowes A, Karnovsky M. Inhibition of rat arterial smooth muscle cell proliferation by heparin: In vivo studies with anticoagulant and nonanticoagulant heparin. Circ Res 1980;46:625-634.
13. [13] Hämmerle H, Betz E, Herr D. Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins. VASA 1991;20:207-215.
14. [14] Betz E, Schlote W. Responses to the vessel walls to chronically applied electrical stimuli. Basic Res Cardiol 1979;74:10-20.
15. [15] Oberhoff M, Herdeg C, Baumbach A, et al. Time course of smooth muscle cell proliferation after local drug delivery of low molecular weight heparin using a porous balloon catheter. Cath Cardiovasc Diag 1997;41:268-274.
16. [16] Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 1990;67:651-659.
17. [17] Hayter A. A proof of the conjecture that the Tukey-Kramer multiple comparisons procedure is conservative. Ann Math Stat 1984;12:61-75.
18. [18] Reidy MA, Schwartz SM. Endothelial regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium. Lab Invest 1981;44:301-308.
19. [19] Lindner V, Reidy MA, Fingerle J. Regrowth of arterial endothelium: Denudation with minimal trauma leads to complete endothelial regrowth. Lab Invest 1989;61:556-560.
20. [20] Lindner V, Majack RA, Reidy MA. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest 1990;85:2004-2008.
21. [21] Wilensky RL, March KL, Gradus-Pizlo I, Sandusky G, Fineberg N, Hathaway DR. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation 1995;92:2995-3005.
22. [22] Weidinger FF, McLenachan JM, Cybulsky MI, et al. Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation 1990;81:1667-1679.
23. [23] More RS, Brack MJ, Underwood MJ, Gershlick AH. Growth factor persistence after vessel wall injury in a rabbit angioplasty model. Am J Cardiol 1994;73:1031-1032.
24. [24] Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury: III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest 1986;54:295-303.
25. [25] Dartsch PC, Voisard R, Bauriedel G, Höfling B, Betz E. Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions. Arteriosclerosis 1990;10:62-75.
26. [26] Casscells W. Migration of smooth muscle and endothelial cells -Critical events in restenosis. Circulation 1992;86:723-729.
27. [27] Gravanis MB, Roubin GS. Histopathological phenomena at the site of percutaneous transluminal coronary angioplasty: The problem of restenosis. Hum Pathol 1988;20:477-485.
28. [28] Joly GA, Schini VB, Vanhoutte PM. Balloon injury and interleukin-β induce nitric oxide synthase activity in rat carotid arteries. Circ Res 1992;71:331-338.
29. [29] Clowes AW, Collazzo RE, Karnovsky MJ. A morphological and permeability study of luminal smooth muscle cells after arterial injury in the rat. Lab Invest 1978;39:141-150.
30. [30] Fishman JA, Ryan GB, Karnovsky MJ. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest 1975;32:339-351.
31. [31] Haudenschild CC, Schwartz SM. Endothelial regeneration, II: restitution of endothelial continuity. Lab Invest 1979;41:407-418.
32. [32] Hirsh J. Low molecular weight heparin. Thromb Haemost 1993;70:204-207.
33. [33] Salzman EW. Low-molecular-weight heparin and other new antithrombotic drugs. New Engl J Med 1992;326:1017-1019.
34. [34] Thornton SC, Mueller SN, Levine EM. Human endothelial cells: Use of heparin in cloning and long-term serial cultivation. Science 1983;222:623-625.
35. [35] Terranova VP, Diflorio R, Lyall RM, Hic S, Friesel R, Maciag T. Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol 1985;101:2330-2334.
36. [36] D'Amore PA. Heparin-endothelial cell interactions. Hemostasis 1990;20:159-165. Suppl. 1.
37. [37] Presta M, Tiberio L, Rusnati M, Dell'era P, Ragnotti G. Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. Cell Regul 1991;2:719-726.
38. [38] Kang SS, Gosselin C, Ren D, Greisler HP. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions. Surgery 1995;118:280-287.
39. [39] Hårdhammar PA, van Beusekom HMM, Emanuelsson HU, et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 1996;93:423-430.
40. [40] Light JT, Bellan JA, Roberts MP, et al. Heparin treatment enhances the recovery of neoendothelial acetylcholine-induced vascular relaxation after balloon catheter injury in the rabbit aorta. Circulation 1993;88(II):413-419.
41. [41] Asahara T, Bauters C, Pastore C, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 1995;91:2793-2801.
42. [42] Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Circulation 1995;92:11-14.
43. [43] Kling D, Holzschuh T, Betz E. Temporal sequence of morphological alterations in artery walls during experimental atherogenesis -Occurrence of leukocytes. Res Exp Med 1987;187:237-250.
44. [44] Camenzind E, Kint PP, Di Mario C, et al. Local intracoronary heparin delivery in man: acute feasibility and longterm result. Circulation 1995;92:2463-2472.
45. [45] Oberhoff M, Hermann T, Diehl C, et al. PILOT-Study: Local drug delivery of low molecular weight heparin for the prevention of restenosis. Circulation 1996;94:1-730.